Z-0235-2022 Class II Ongoing
FDA device recall Z-0235-2022 was initiated by Bio-Rad Laboratories, Inc. on September 17, 2021 and is designated Class II. Reason for recall: Due to two issues: 1) Customer complaints associated with greater than expected Rapid Plasma Reagin (RPR) reactivity which does not confirm with treponemal antibody test which may be due to a positive… The recall status is ongoing. Affected quantity: 11,610 units.
Recall Details
- Product Type
- Devices
- Report Date
- November 24, 2021
- Initiation Date
- September 17, 2021
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 11,610 units
Product Description
Reason for Recall
Distribution Pattern
Worldwide Distribution: U.S.(nationwide) including states of: AK, AL, AZ, CA, CO, CT, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, Puerto Rico, SC, SD, TN, TX, UT, VA, WA, WI, and WV; O.U.S.(foreign) countries of: France, Germany, Israel, Italy, Russian Federation, South Africa, Spain, and Taiwan.